在一组节段性早老综合征患者中鉴定出 ERCC4 变体。
ERCC4 variants identified in a cohort of patients with segmental progeroid syndromes.
机构信息
Division of Genetic Medicine, Department of Pediatrics, University of Washington, Seattle, Washington.
Department of Molecular Medicine, Center on Aging, The Scripps Research Institute, Jupiter, Florida.
出版信息
Hum Mutat. 2018 Feb;39(2):255-265. doi: 10.1002/humu.23367. Epub 2017 Nov 17.
Pathogenic variants in genes, which encode DNA repair and damage response proteins, result in a number of genomic instability syndromes with features of accelerated aging. ERCC4 (XPF) encodes a protein that forms a complex with ERCC1 and is required for the 5' incision during nucleotide excision repair. ERCC4 is also FANCQ, illustrating a critical role in interstrand crosslink repair. Pathogenic variants in this gene cause xeroderma pigmentosum, XFE progeroid syndrome, Cockayne syndrome (CS), and Fanconi anemia. We performed massive parallel sequencing for 42 unsolved cases submitted to the International Registry of Werner Syndrome. Two cases, each carrying two novel heterozygous ERCC4 variants, were identified. The first case was a compound heterozygote for: c.2395C > T (p.Arg799Trp) and c.388+1164_792+795del (p.Gly130Aspfs*18). Further molecular and cellular studies indicated that the ERCC4 variants in this patient are responsible for a phenotype consistent with a variant of CS. The second case was heterozygous for two variants in cis: c.[1488A > T; c.2579C > A] (p.[Gln496His; Ala860Asp]). While the second case also had several phenotypic features of accelerated aging, we were unable to provide biological evidence supporting the pathogenic roles of the associated ERCC4 variants. Precise genetic causes and disease mechanism of the second case remains to be determined.
基因编码的 DNA 修复和损伤反应蛋白的致病变体导致多种基因组不稳定综合征,具有加速衰老的特征。ERCC4(XPF)编码一种与 ERCC1 形成复合物的蛋白质,是核苷酸切除修复中 5' 切口所必需的。ERCC4 也是 FANCQ,说明其在链间交联修复中具有关键作用。该基因的致病变体导致着色性干皮病、XFE 早老综合征、 Cockayne 综合征(CS)和范可尼贫血。我们对提交给 Werner 综合征国际注册处的 42 例未解决病例进行了大规模平行测序。确定了两例各携带两个新的杂合 ERCC4 变体的病例。第一个病例是复合杂合子:c.2395C>T(p.Arg799Trp)和 c.388+1164_792+795del(p.Gly130Aspfs*18)。进一步的分子和细胞研究表明,该患者的 ERCC4 变体导致与 CS 变体一致的表型。第二个病例是顺式两种变体的杂合子:c.[1488A>T;c.2579C>A](p.[Gln496His;Ala860Asp])。虽然第二个病例也有几个加速衰老的表型特征,但我们无法提供支持相关 ERCC4 变体致病作用的生物学证据。第二个病例的确切遗传原因和疾病机制仍有待确定。